Jim Coons is a cardiology pharmacotherapy specialist at UPMC and clinical researcher who manages the care of patients with cardiovascular diseases and conducts clinical outcomes and translational research related to this patient population. He is also a faculty member in the Department of Pharmacy and Therapeutics and the Center for Clinical Pharmaceutical Sciences at the University of Pittsburgh School of Pharmacy. He has been recognized as a Fellow of the American College of Clinical Pharmacy and the American College of Cardiology, and is a Board-Certified Cardiology Pharmacist. He has been active in clinical practice for nearly 20 years, having managed patients in multiple cardiovascular settings. He is a core part of the PreCISE-Rx and Test2Learn teams which implement clinical pharmacogenomics, research, and educational initiatives.
Philip Empey, UPitt
Mary V. Relling, St. Jude Children’s Research Hospital
Stuart Scott, Stanford
Pharmacists have long recognized that using unique patient characteristics to guide pharmacotherapy decision-making can improve drug response and mitigate drug-associated risks. Age, weight, and dietary habits were among the first patient-specific characteristics used to individualize pharmacotherapy. As technologies advanced, analytic tools that measure surrogate markers of liver and renal function, together with drug concentrations in biological fluids, were adopted to optimize therapeutic regimens. Cutting-edge genomic technologies are now being integrated into patient care for the selection of targeted therapies and identification of those at increased risk of poor pharmacotherapy outcomes. We’re excited to bring together experts who are advancing pharmacogenomics at scale through cutting edge clinical implementation, research, and education.